Pharma Snubs WHO Call To Pool COVID-19 Patents
WHO Says Initiative Aims To Ensure Equitable Access
Executive Summary
Almost three dozen countries have shown support for the alternative mechanism put forward by the World Health Organization to ensure that IP issues do not stand in the way of providing access to COVID-19 medicines, vaccines and diagnostics to ‘all of humanity.’
You may also be interested in...
EU Urges Free Access To Publicly Funded COVID-19 Research Results
A “manifesto” to encourage the wider dissemination of COVID-19 research is the latest in a series of EU and international initiatives to quickly find treatments, vaccines and tests for the coronavirus.
Coronavirus Update: More Drugs Enter Trials, UK To Host Latest Vaccine Summit
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national, European and global level.
WHO ‘Showed Leadership’ In Dealing With COVID-19, Says Interim Inquiry
An interim independent assessment of the WHO’s response to the COVID-19 pandemic has supported the organization’s work. But will be it enough to convince critics as the WHO faces the threat of permanently losing funds from its biggest donor, the US?